The TxCell Scanning Laser Delivery System (Iridex), which allows physicians to deliver laser power in a multi-spot scanning mode, has received FDA 510(k) and CE clearance.
Kodiak Sciences reports positive topline results from BEACON Phase 3 study of tarcocimab in patients with retinal vein occlusion
Inflammatory bowel disease does not have ocular manifestations
Innovent announces first patient dosed in Phase 1 study of IBI324 in patients with diabetic macular edema
